Human papillomavirus infection and anxiety: Analyses in women with low-grade cervical cytological abnormalities unaware of their infection status

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Johnson, Candice Y ^a   Sharp, Linda ^b   Cotton, Seonaidh C ^c   Harris, Cheryl A ^d   Gray, Nicola M ^e   Little, Julian ^f  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d OTTAWA REGIONAL CANCER CENTRE   (Canada)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL LABORATORY RESULT; ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; CANCER RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNICITY; FEAR; FEMALE; FOLLOW UP; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PSYCHOLOGIC ASSESSMENT; RISK FACTOR; SMOKING; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; ALPHAPAPILLOMAVIRUS; ANXIETY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ISOLATION AND PURIFICATION; LIFESTYLE; MIDDLE AGED; PATHOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; UTERINE CERVIX; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; ANXIETY; CERVIX UTERI; FEMALE; GREAT BRITAIN; HUMANS; LIFE STYLE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAPILLOMAVIRUS INFECTIONS; RISK FACTORS;

EID: 79959253821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021046     Document Type: Article

References (36)

1. Tjalma WA, Van Waes TR, Van den Eeden LE, Bogers JJ, (2005) Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 19: 469-483.
2. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, et al. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7: 453-459.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV, (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
4. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, et al. (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121: 621-632.
5. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, et al. (2006) Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24: S3/78-S73/89.
6. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, et al. (2009) Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 101: 1612-1623.
7. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, et al. (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11: 249-257.
8. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, et al. (2004) Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ 328: 1293.
9. McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, et al. (2004) Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 111: 1437-1443.
10. McCaffery K, Waller J, Nazroo J, Wardle J, (2006) Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect 82: 169-174.
11. Kwan TT, Cheung AN, Lo SS, Lee PW, Tam KF, et al. (2011) Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study. Acta Obstet Gynecol Scand 90: 445-451.
12. Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, et al. (2009) ARTISTIC: a randomised trial of human papillmavirus (HPV) testing in primary cervical screening. Health Technol Assess 13: 1-150, iii-iv.
13. Cotton SC, Sharp L, Seth R, Masson LF, Little J, et al. (2007) Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer 97: 133-139.
14. Lewis-Fernandez R, Hinton DE, Laria AJ, Patterson EH, Hofmann SG, et al. (2010) Culture and the anxiety disorders: recommendations for DSM-V. Depress Anxiety 27: 212-229.
15. Weisberg RB, (2009) Overview of generalized anxiety disorder: epidemiology, presentation, and course. J Clin Psychiatry 70: 4-9.
16. Mykletun A, Overland S, Aaro LE, Liabo HM, Stewart R, (2008) Smoking in relation to anxiety and depression: evidence from a large population survey: the HUNT study. Eur Psychiatry 23: 77-84.
17. Cotton SC, Sharp L, Little J, Duncan I, Alexander L, et al. (2006) Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemp Clin Trials 27: 449-471.
18. TOMBOLA Group (2009) Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multricentre randomised controlled trial. BMJ 339: b2546.
19. TOMBOLA Group (2009) Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ 339: b.2548.
20. Evans DM, Hudson EA, Brown CL, Boddington MM, Hughes HE, et al. (1986) Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology. J Clin Pathol 39: 933-944.
21. Kurman RJ, Solomon D, (1996) The Bethesda system for reporting cervical/vaginal cytologic diagnoses New York Springer-Verlag.
22. Herbert A, (1995) Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology Sheffield NHSCSP Publications.
23. Johnson J, Patnick J, NHS Cancer Screening Programmes (2000) Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology Sheffield NHS Cancer Screening Programmes.
24. Zigmond AS, Snaith RP, (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370.
25. Snaith RP, (2003) The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes 1: 29.
26. Gray NM, Sharp L, Cotton SC, Avis M, Philips Z, et al. (2005) Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear results and its subsequent management: the TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal Smears) trial. Qual Life Res 14: 1553-1562.
27. Bjelland I, Dahl AA, Haug TT, Neckelmann D, (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52: 69-77.
28. Carstairs V, Morris R, (1989) Deprivation: explaining differences in mortality between Scotland and England and Wales. BMJ 299: 886-889.
29. Waller J, McCaffery K, Wardle J, (2004) Beliefs about the risk factors for cervical cancer in a British population sample. Prev Med 38: 745-753.
30. Lin KM, (2001) Biological differences in depression and anxiety across races and ethnic groups. J Clin Psychiatry 62: 13-19.
31. Miller AH, Capuron L, Raison CL, (2005) Immunologic influences on emotion regulation. Clin Neurosci Res 4: 325-333.
32. Russo S, Kema IP, Fokkema MR, Boon JC, Willemse PH, et al. (2003) Tryptophan as a link between psychopathology and somatic states. Psychosom Med 65: 665-671.
33. Capuron L, Miller AH, (2004) Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56: 819-824.
34. Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, et al. (2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 100: 513-517.
35. Gray NM, Sharp L, Cotton SC, Masson LF, Little J, et al. (2006) Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer 94: 1253-1262.
36. Sharp L, Cotton S, Gray N, Avis M, Russell I, et al. (2011) Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for colposcopy: a randomised controlled trial. Br J Cancer 104: 255-264.